Presentation of RadisMed, a biomed start-up developing innovative drugs and diagnostic products for rare diseases

1. RadisMed
Medical Solutions for Rare Diseases
Company presentation

2. Positioning
Company description
• RadisMed is a biomed specialty
company focused on niche markets
• RadisMed develops innovative drugs
and diagnostic products for unexplored
life-threatening rare diseases
• RadisMed also offers several preclinical
services to other companies

3. Unmet needs
Rare diseases
Rare Disease = Small number of patients
Big Pharmas tend to explore more
common diseases
Patients suffer from life-threatening
diseases with two main needs
No drugs to No diagnostic
treat them products

4. Three business lines
RadisMed structure
Orphan drug discovery and early
development
Genetic diagnostics
Services

5. RadisMed Orphan Drugs
Drug discovery and development
License License
in out
Discovery Pre-clinical Clinical I Clinical II Clinical III Market
Value generation
Drug
value +
Value retention
Development phase

6. RadisMed Orphan Drugs
Technology: Drosophila
Use of Drosophila as screening tool to identify orphan drugs
Info on
diseases
Therapeutic
Ideal model
target
for genetic
validation +
diseases
in vivo data
Bank of
molecules
• Cost effective drug screening (cheap high throughput)
• Higher chances of Pre-clinical/Clinical success
• Highly flexible platform with great capacity to adapt to
market requirements

7. RadisMed Orphan Drugs
Development pipeline
Oncology Program 4 indications
Nervous System Program 2 indications
Reproductive System Program 1 indication

8. RadisMed Diagnostics
Genetic diagnostic products
Use of Microarray to detect genetic
alterations
Disease Internal development and
info commercialization
Discovery Product Development Clinical Testing Market

9. RadisMed Diagnostics
Development pipeline
Discovery Product Development Clinical Testing Market
Metabolic diseases
Nervous system

10. RadisMed Services
Flexible platform
Use of Drosophila for Preclinical tests
High Throughput Screening
Toxicity assays
Model
Client-specific projects: ad-
hoc models

11. RadisMed in short
High growth potential
Focused on rare diseases
3 Business lines:
• RadisMed Orphan Drugs
• RadisMed Diagnostics
• RadisMed Services
Core activities based on two platforms:
• Drosophila melanogaster
• Molecular diagnostic technology

12. Thank you
RadisMed
Contact:
info@radismed.com